This is a genuinely novel clinical phenomenon
WEDNESDAY, July 23, 2025 (HealthDay News) -- Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with metformin, according to a study published online July 22 in BMJ Open Diabetes Research & Care.Mingyang Sun, from the People's Hospital of Zhengzhou University in China, and colleagues conducted a retrospective cohort study using data from a global health research network between 2004 and 2024 to examine the comparative effectiveness of GLP-1 RAs and metformin in reducing dementia risk
This seems fine at first because it is what they know
The Mediterranean diet has the strongest evidence base, characterised by high consumption of vegetables, fruits, whole grains, legumes, nuts, and olive oil, with moderate fish intake and limited red meat and processed foods
This has opened the door for delivery systems that offer strong absorption with at-home convenience
Practical steps to lower heat-related dangers while on GLP-1 drugs Simple habits can reduce risk without stopping therapy
